Table 1.

Correlation of Cox-2 & Fox-M1 co-expression with clinico-pathological parameters in colorectal carcinoma^a

	Total		Both high		Any-1-low		p value
	Number	Percent	Number	Percent	Number	Percent
Total number of cases	697		232	33.3	465	66.7
Age
≤50 years	229	32.9	90	39.3	139	60.7	0.0191
>50 years	468	67.1	142	30.3	326	69.7
Sex
Male	358	51.4	116	32.4	242	67.6	0.6111
Female	339	48.6	116	34.2	223	65.8
Tumour Site
Left colon	548	82.3	176	32.1	372	67.9	0.5821
Right colon	118	17.7	41	34.8	77	65.2
Histological Type
Adenocarcinoma	628	90.1	200	31.9	428	68.1	0.0174
Mucinous Carcinoma	69	9.9	32	46.4	37	53.6
Tumour Stage
I	80	12.2	25	31.3	55	68.7	0.4160
II	233	35.4	75	32.2	158	67.8
III	266	40.4	98	36.8	168	63.2
IV	79	12.0	22	27.8	57	72.2
Differentiation
Well	66	9.5	21	31.8	45	68.2	0.3709
Moderate	549	78.8	178	32.4	371	67.6
Poor	82	11.8	33	40.2	49	59.8
Ki-67
High	590	87.7	209	35.4	381	64.6	0.0004
Low	83	12.3	14	16.9	69	83.1
p-AKT
High	454	72.3	169	37.2	285	62.8	0.0214
Low	174	27.7	48	27.6	126	72.4
MMP-9
High	342	52.2	129	37.7	213	62.3	0.0116
Low	313	47.8	89	28.4	224	71.6
Survival
OS 5 Years				73.6		68.5	0.4796

^aData were not available for (Tumor Site NA = 31), (Tumor Stage NA = 39), (Ki-67 NA = 24), (p-AKT NA = 69) and (MMP-9 NA = 42)